Medical Devices Startups

Phagenesis develops the Phagenyx System, a medical device that uses pharyngeal electrical stimulation to restore swallowing control in stroke patients with dysphagia, reducing hospital stays and aspiration risk.

3 investors

Pharmaron is a life science contract research and manufacturing service provider covering drug discovery, preclinical and clinical development, and commercialization. It serves pharmaceutical and biotech partners across small molecules, biologics, and cell and gene therapy (CGT) products.

3 investors

Physcient develops Differential Dissection, a powered blunt surgical dissector that separates soft tissues connecting other tissues without cutting or burning, leaving blood vessels, organ capsules, and nerve sheaths intact. The device is aimed at surgeons to help identify and maintain the correct surgical plane and reduce procedure times.

3 investors

PIPRA develops AI and deep-tech tools that predict and diagnose postoperative delirium, stratifying pre-surgical patients into risk groups to support clinicians. The Switzerland-based company serves hospitals, insurers, and clinical teams aiming to reduce postoperative complications and associated costs.

3 investors

Podimetrics offers a remote monitoring and care program for people with complex diabetes, centered on the SmartMat device that collects foot-health data to enable early intervention and prevent complications such as amputations. It serves payors, healthcare providers, and employers seeking to reduce costs and improve outcomes for high-risk diabetic populations.

3 investors

Precision Medicine Group provides biomarker-driven research and development services and commercialization support for pharmaceutical and life science companies across drug development, manufacturing, and market access.

3 investors

Profound Medical develops the MRI-guided TULSA Procedure (TULSA-PRO), an incision-free transurethral ultrasound ablation system for treating prostate tissue in men with conditions such as localized prostate cancer. The device uses real-time MRI temperature monitoring and closed-loop feedback to ablate targeted prostate tissue while aiming to preserve erectile function and urinary continence.

3 investors

Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue. The company's Lumee platform addresses oxygen monitoring for vascular surgery patients and continuous glucose monitoring for diabetes and prediabetes patients.

3 investors

Progentos develops small-molecule therapeutics to stimulate myelin regeneration in multiple sclerosis patients by activating oligodendrocyte progenitor cells. The company targets the significant unmet need for remyelinating treatments that could repair damage caused by MS and potentially restore lost function.

3 investors

Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions. The company operates in the medical imaging and medical device sector.

3 investors

ProxiHealthcare develops bioelectric current technology to address microbial biofilm problems, backed by around 80 patents and global certifications. The company applies its patented approach at the intersection of medicine and engineering to create healthcare and oral care products.

3 investors

PSYONIC develops the Ability Hand, a touch-sensing bionic hand with sensory feedback and motor control for prosthetic users and robotics applications. The company positions the device as faster than other bionic hands and priced to be covered by Medicare and most private insurers.

3 investors

Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention. The company serves the precision healthcare and life sciences research market with biomarker detection tools.

3 investors

Quantum-Si develops benchtop instruments (Platinum and Platinum Pro) for single-molecule, single-amino-acid resolution protein sequencing, used to identify proteins, protein variants, and post-translational modifications. The proteomics technology serves researchers and diagnostics labs working in biomarker discovery, disease mechanisms, and drug development.

3 investors

QuantuMDx develops point-of-care molecular diagnostics platforms and assays for detecting infectious diseases including sexually transmitted infections, antimicrobial resistance, respiratory viruses, and other pathogens. The company's Q-POC platform delivers rapid PCR test results in approximately 30 minutes for use in clinical, care home, and healthcare settings.

3 investors

Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies. The company offers modular products for prostate, brain, liver, and breast MRI analysis, plus a data management platform for clinical research and drug development programs.

3 investors

QUiCKR develops rapid genetic modification quantification kits for cell and gene therapy R&D programs, analyzing structural variants, edits, and genome integrity to accelerate development timelines and reduce costs.

3 investors

GE Healthcare provides AI-enabled medical devices and diagnostic solutions for healthcare providers worldwide, helping clinicians improve diagnostic accuracy and clinical decision-making. The company operates across medical imaging, monitoring, and healthcare IT with over 130 years of innovation history.

3 investors

REEV develops intelligent wearable robotic systems, including a robotic knee orthosis and gait-analysis technology, to restore mobility for people with movement disorders. The company serves patients with neurological and mobility conditions, operating in the medical robotics and rehabilitation technology sector.

3 investors

Regenosine is developing a regenerative therapy for osteoarthritis and other indications, based on an intra-articular injection of a proprietary liposomal adenosine formula designed for slow release in joints. The therapy is positioned as disease-modifying, aiming to reduce joint pain, halt disease progression, and promote cartilage regeneration.

3 investors

Remedy Logic provides an AI tool that analyzes spine MRI studies, automating measurements and detecting pathology to assist radiologists during interpretation. It integrates with existing PACS/RIS systems and is aimed at radiologists and healthcare facilities.

3 investors

Reprieve Cardiovascular develops a decongestion management system that uses real-time patient data to guide and personalize diuretic therapy for fluid removal in heart failure patients. The technology gives physicians and care teams visibility and control over treatment to accelerate fluid removal while managing kidney injury risk, targeting hospital-based heart failure care in the U.S.

3 investors

RespirAq develops the RespirAq Active Humidifier System, a compact, battery-powered device that provides active heated humidification for mechanically ventilated patients without an external water supply, using a thermo-responsive smart material to capture and release moisture from the patient's breath. The product is designed for invasive and non-invasive ventilation across care settings in the respiratory care market.

3 investors

Restera is a clinical-stage medical technology company developing a miniature neurostimulation implant to treat Obstructive Sleep Apnea (OSA). The device is injected through a needle in an outpatient procedure and stimulates targeted nerves during sleep to open the airway and improve breathing.

3 investors